Joseph J Cadden, MD
Internal Medicine · Los Angeles
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 33 years
- Graduated 1993
Offices
1 location · Comprehensive Community Health Centers Inc · 47 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Cadden’s office at (323) 344-4144 to ask if they take your plan before you enroll.
California Medical Board record
Licence A63095 · Current
Licensed to practise in California · since 1997 · expires 2027-02-28 · St. George'S University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Infectious Disease
Original Medicare doctor bills
$318
Medicare paid this office $318 for 31 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Hemoglobin a1c level | 15 | $162 | $10 |
| Blood glucose (sugar) level | 24 | $112 | $4 |
Who their Medicare patients are
31 Original Medicare patients in 2024. Average age 68 · Women 61% · Also on Medicaid 100% · Health risk score 1.42. At or below the middle of the specialty; the typical infectious disease clinician is at 3.
Conditions among them: High blood pressure 75% · Diabetes 75%.
The office billed $576, Medicare allowed $321 and paid $318; for 53 services of 5 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 31 | 53 | 68 | 1.42 | $576 | $318 |
| 2021 | 191 | 566 | 69 | 1.53 | $22,791 | $12,907 |
| 2019 | 66 | 119 | 69 | 3.82 | $30,170 | $9,360 |
| 2018 | 217 | 528 | 68 | 3.90 | $138,520 | $45,884 |
| 2017 | 268 | 775 | 67 | 3.31 | $195,090 | $65,637 |
| 2016 | 245 | 704 | 65 | 3.85 | $178,690 | $57,585 |
| 2015 | 229 | 818 | 67 | 3.58 | $204,810 | $68,289 |
| 2014 | 249 | 820 | 66 | 3.34 | $209,404 | $67,730 |
| 2013 | 193 | 585 | 65 | 4.04 | $150,600 | $46,634 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2021: 8 services
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; first dose | 104 | $4,767 | $45 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; second dose | 82 | $3,723 | $45 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, dna, spike protein, adenovirus type 26 (ad26) vector, preservative free, 5x1010 viral particles/0.5ml dosage; single dose | 39 | $1,771 | $45 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; first dose | 29 | $1,362 | $45 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; second dose | 24 | $1,180 | $45 |
| Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage, for intramuscular use | 119 | $2 | $0 |
| Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted, for intramuscular use | 33 | $1 | $0 |
| Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, dna, spike protein, adenovirus type 26 (ad26) vector, preservative free, 5x1010 viral particles/0.5ml dosage, for intramuscular use | 39 | $0 | $0 |
2019: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $3,122 | $89 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 32 | $2,939 | $84 |
| Long return visit (40+ min) | 20 | $1,969 | $82 |
2018: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 118 | $24,413 | $88 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 73 | $6,507 | $86 |
| Long return visit (40+ min) | 36 | $6,142 | $87 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 39 | $4,642 | $113 |
| Return visit (30+ min) | 25 | $1,762 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $1,309 | $60 |
2017: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 157 | $38,421 | $88 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 105 | $9,442 | $86 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 40 | $4,879 | $116 |
| Long return visit (40+ min) | 28 | $4,482 | $80 |
| Return visit (30+ min) | 42 | $3,782 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 51 | $3,254 | $61 |
2016: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 151 | $35,230 | $86 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 82 | $6,954 | $84 |
| Long return visit (40+ min) | 30 | $4,921 | $88 |
| Return visit (30+ min) | 52 | $4,352 | $59 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $2,954 | $114 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $1,397 | $54 |
2015: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 141 | $44,645 | $88 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 80 | $7,238 | $86 |
| Long return visit (40+ min) | 26 | $5,454 | $87 |
| Return visit (30+ min) | 48 | $5,319 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 48 | $3,506 | $62 |
2014: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 157 | $42,688 | $87 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 93 | $8,123 | $85 |
| Long return visit (40+ min) | 31 | $5,953 | $80 |
| Return visit (30+ min) | 54 | $5,638 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $1,447 | $60 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,381 | $115 |
| New patient visit (45+ min) | 13 | $1,286 | $99 |
2013: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 106 | $27,979 | $84 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 87 | $7,439 | $81 |
| Long return visit (40+ min) | 25 | $4,345 | $82 |
| Return visit (30+ min) | 37 | $3,540 | $54 |
| New patient visit (45+ min) | 12 | $1,270 | $106 |
Medicaid work
$1,512,780 in 2024
Medicaid paid $1,512,780 for 36,677 billed services this clinician did in 2024, up to 746 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 6,871 | $1,407,455 |
| Short return visit (20+ min) | 5,172 | $23,746 |
| Short return visit | 3,236 | $12,415 |
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; 40-64 years | 401 | $9,912 |
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; 18-39 years | 463 | $9,767 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 1,449 | $7,900 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 1,372 | $7,360 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years | 282 | $7,034 |
| BODY MASS INDEX DOCD | 3,872 | $6,835 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 819 | $4,520 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 220 | $2,881 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 515 | $2,700 |
| 2024 | 36,677 | 39 | 746 | $1,512,780 |
| 2023 | 13,611 | 26 | 341 | $525,714 |
| 2021 | 1,905 | 26 | 303 | $37,276 |
| 2019 | 169 | 3 | 31 | $3,381 |
| 2018 | 1,476 | 21 | 40 | $12,331 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 2,491 | $488,725 |
| Short return visit (20+ min) | 1,879 | $11,476 |
| Short return visit | 1,488 | $6,800 |
| BODY MASS INDEX DOCD | 1,770 | $3,105 |
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; 18-39 years | 138 | $3,081 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 450 | $2,490 |
| New patient visit (30+ min) | 146 | $2,209 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 394 | $2,155 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 295 | $1,520 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years | 37 | $1,209 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 208 | $1,040 |
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; 40-64 years | 48 | $793 |
2021
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage; first dose | 399 | $13,021 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage; second dose | 337 | $10,975 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; first dose | 203 | $6,080 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; second dose | 160 | $4,610 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x1010 viral particles/0.5 mL dosage; single dose | 98 | $2,590 |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage, for intramuscular use | 89 | $0 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 73 | $0 |
| COMPREHENSIVE METABOLIC PANEL | 52 | $0 |
| Blood test, lipids (cholesterol and triglycerides) | 33 | $0 |
| Urinalysis; microscopic only | 12 | $0 |
| Measurement of direct bilirubin | 12 | $0 |
| Measurement of vitamin D 25 hydroxy | 24 | $0 |
2019
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 57 | $1,509 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 57 | $1,504 |
| OFF/OP EST MAY X REQ PHY/QHP | 55 | $369 |
2018
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 129 | $5,483 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 180 | $2,587 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 180 | $2,579 |
| OFF/OP EST MAY X REQ PHY/QHP | 53 | $729 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; HIV-1 antigen(s), with HIV-1 and HIV-2 antibodies | 25 | $655 |
| Contraceptive supply, condom, male, each | 25 | $298 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 15 | $0 |
| COMPREHENSIVE METABOLIC PANEL | 154 | $0 |
| Blood test, lipids (cholesterol and triglycerides) | 88 | $0 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 91 | $0 |
| Hemoglobin A1C level | 74 | $0 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 95 | $0 |
Drugs they prescribed that Part D paid
$348,388
Pharmacies billed $348,388 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
3,231 generic and 578 brand-name prescriptions · $348,388 in drug cost · 74 antibiotic prescriptions to 55 people · 14 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 117 | $86,860 | $742 |
| Ozempic | 33 | $35,594 | $1,079 |
| Eliquis | 23 | $21,163 | $920 |
| Januvia | 24 | $20,833 | $868 |
| Trulicity | 15 | $14,212 | $947 |
See all 78 drugs
| Jardiance | 117 | $86,860 | $742 |
| Ozempic | 33 | $35,594 | $1,079 |
| Eliquis | 23 | $21,163 | $920 |
| Januvia | 24 | $20,833 | $868 |
| Trulicity | 15 | $14,212 | $947 |
| Farxiga | 14 | $8,864 | $633 |
| Atorvastatin | 299 | $2,260 | $8 |
| Levothyroxine | 83 | $2,068 | $25 |
| Lantus Solostar | 19 | $1,921 | $101 |
| Albuterol Sulfate Hfa | 58 | $1,424 | $25 |
| Metformin | 278 | $1,414 | $5 |
| Wixela Inhub | 13 | $1,324 | $102 |
| Amlodipine Besylate-Benazepril | 131 | $1,279 | $10 |
| Ventolin Hfa | 18 | $1,194 | $66 |
| Metoprolol | 68 | $975 | $14 |
| Lantus | 16 | $969 | $61 |
| Pantoprazole | 142 | $895 | $6 |
| Gabapentin | 81 | $825 | $10 |
| Amlodipine Besylate | 189 | $760 | $4 |
| Diclofenac | 20 | $624 | $31 |
| Potassium Chloride | 47 | $616 | $13 |
| Valsartan | 22 | $576 | $26 |
| Lisinopril | 108 | $534 | $5 |
| Carbamazepine Er | 11 | $499 | $45 |
| Omega-3 Acid Ethyl Esters | 13 | $494 | $38 |
| Rosuvastatin | 32 | $492 | $15 |
| Sumatriptan | 11 | $468 | $43 |
| Famotidine | 44 | $454 | $10 |
| Losartan | 66 | $451 | $7 |
| Omeprazole | 45 | $428 | $10 |
| Fluticasone Propionate | 63 | $424 | $7 |
| Montelukast | 27 | $392 | $15 |
| Ibuprofen | 57 | $336 | $6 |
| Nitroglycerin | 14 | $279 | $20 |
| Chlorthalidone | 22 | $269 | $12 |
| Losartan-Hydrochlorothiazide | 34 | $261 | $8 |
| Brimonidine | 13 | $259 | $20 |
| Hydrochlorothiazide | 97 | $257 | $3 |
| Simvastatin | 31 | $246 | $8 |
| Tamsulosin | 40 | $239 | $6 |
| Pioglitazone | 19 | $224 | $12 |
| Baclofen | 16 | $201 | $13 |
| Clopidogrel | 32 | $200 | $6 |
| Cyclobenzaprine | 16 | $199 | $12 |
| Valsartan-Hydrochlorothiazide | 15 | $193 | $13 |
| Hydralazine | 19 | $190 | $10 |
| Mirtazapine | 18 | $189 | $11 |
| Glimepiride | 21 | $188 | $9 |
| Doxepin | 14 | $186 | $13 |
| Clonidine | 32 | $175 | $5 |
| Furosemide | 56 | $173 | $3 |
| Hydrocortisone | 21 | $172 | $8 |
| Propranolol | 16 | $170 | $11 |
| Naproxen | 28 | $169 | $6 |
| Finasteride | 18 | $168 | $9 |
| Lisinopril-Hydrochlorothiazide | 22 | $151 | $7 |
| Trazodone | 42 | $143 | $3 |
| Glipizide | 28 | $132 | $5 |
| Latanoprost | 13 | $115 | $9 |
| Olmesartan Medoxomil | 13 | $104 | $8 |
| Alendronate | 20 | $99 | $5 |
| Irbesartan | 11 | $98 | $9 |
| Metoprolol | 18 | $96 | $5 |
| Carvedilol | 22 | $95 | $4 |
| Sertraline | 30 | $89 | $3 |
| Triamcinolone Acetonide | 20 | $86 | $4 |
| Escitalopram | 14 | $79 | $6 |
| Benazepril | 17 | $78 | $5 |
| Atenolol | 18 | $60 | $3 |
| Isoniazid | 13 | $51 | $4 |
| Quetiapine | 18 | $50 | $3 |
| Sulfamethoxazole-Trimethoprim | 17 | $47 | $3 |
| Azithromycin | 16 | $45 | $3 |
| Citalopram Hbr | 14 | $31 | $2 |
| Meloxicam | 15 | $29 | $2 |
| Prednisone | 14 | $26 | $2 |
| Warfarin | 18 | $26 | $1 |
| Methimazole | 11 | $14 | $1 |
Year by year
| 2024 | 3,847 | 312 | None | 15% | $348,388 |
| 2023 | 1,728 | 193 | 0% (0) | 16% | $149,232 |
| 2021 | 14 | None | 0% (0) | None | $16,275 |
| 2020 | 50 | 13 | 0% (0) | 30% | $36,083 |
| 2019 | 982 | 57 | None | 41% | $873,241 |
| 2018 | 1,371 | 74 | None | 45% | $1,096,866 |
| 2017 | 1,227 | 77 | None | 40% | $867,578 |
| 2016 | 1,009 | 75 | 1% (14) | 41% | $599,873 |
| 2015 | 1,066 | 75 | None | None | $573,346 |
| 2014 | 937 | 75 | None | None | $456,358 |
| 2013 | 958 | 70 | None | None | $460,301 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 37 drugs
| Jardiance | 31 | $23,325 | $752 |
| Ozempic | 18 | $17,378 | $965 |
| Eliquis | 14 | $8,275 | $591 |
| Farxiga | 11 | $7,933 | $721 |
| Januvia | 12 | $6,706 | $559 |
| Lantus | 14 | $4,252 | $304 |
| Atorvastatin | 99 | $1,791 | $18 |
| Albuterol Sulfate Hfa | 38 | $1,479 | $39 |
| Metformin | 138 | $989 | $7 |
| Potassium Chloride | 24 | $984 | $41 |
| Levothyroxine | 35 | $805 | $23 |
| Pantoprazole | 69 | $795 | $12 |
| Gabapentin | 44 | $791 | $18 |
| Amlodipine Besylate | 90 | $725 | $8 |
| Lisinopril | 95 | $651 | $7 |
| Diclofenac | 20 | $501 | $25 |
| Fluticasone Propionate | 36 | $407 | $11 |
| Trazodone | 53 | $399 | $8 |
| Ibuprofen | 33 | $374 | $11 |
| Losartan | 28 | $343 | $12 |
| Cyclobenzaprine | 14 | $330 | $24 |
| Rosuvastatin | 12 | $302 | $25 |
| Metoprolol | 17 | $244 | $14 |
| Simvastatin | 20 | $243 | $12 |
| Glipizide | 24 | $234 | $10 |
| Hydrochlorothiazide | 24 | $184 | $8 |
| Tamsulosin | 16 | $172 | $11 |
| Clopidogrel | 17 | $156 | $9 |
| Famotidine | 13 | $146 | $11 |
| Omeprazole | 18 | $126 | $7 |
| Furosemide | 31 | $113 | $4 |
| Azithromycin | 15 | $95 | $6 |
| Citalopram Hbr | 14 | $87 | $6 |
| Levofloxacin | 13 | $87 | $7 |
| Buspirone | 14 | $79 | $6 |
| Sertraline | 11 | $44 | $4 |
| Prednisone | 19 | $41 | $2 |
2019: 32 drugs
| Tivicay | 68 | $148,251 | $2,180 |
| Biktarvy | 42 | $132,892 | $3,164 |
| Descovy | 61 | $109,812 | $1,800 |
| Genvoya | 24 | $74,344 | $3,098 |
| Prezcobix | 37 | $74,025 | $2,001 |
| Odefsey | 25 | $71,838 | $2,874 |
| Triumeq | 20 | $60,255 | $3,013 |
| Selzentry | 24 | $38,596 | $1,608 |
| Juluca | 13 | $35,576 | $2,737 |
| Voriconazole | 11 | $30,750 | $2,795 |
| Fluconazole | 15 | $6,350 | $423 |
| Vancomycin | 16 | $4,415 | $276 |
| Cefepime | 11 | $2,745 | $250 |
| Moxifloxacin | 11 | $2,532 | $230 |
| Ceftriaxone | 12 | $1,400 | $117 |
| Ventolin Hfa | 22 | $1,286 | $58 |
| Gabapentin | 25 | $690 | $28 |
| Atorvastatin | 67 | $403 | $6 |
| Enalapril Maleate | 30 | $394 | $13 |
| Amoxicillin-Clavulanate Potass | 12 | $336 | $28 |
| Levofloxacin | 14 | $292 | $21 |
| Sulfamethoxazole-Trimethoprim | 29 | $285 | $10 |
| Azithromycin | 15 | $272 | $18 |
| Levothyroxine | 11 | $223 | $20 |
| Cephalexin | 13 | $182 | $14 |
| Omeprazole | 33 | $179 | $5 |
| Amlodipine Besylate | 43 | $131 | $3 |
| Ibuprofen | 11 | $104 | $9 |
| Benazepril | 17 | $76 | $4 |
| Citalopram Hbr | 14 | $44 | $3 |
| Metoprolol | 15 | $32 | $2 |
| Tamsulosin | 14 | $31 | $2 |
2018: 44 drugs
| Tivicay | 101 | $183,271 | $1,815 |
| Biktarvy | 51 | $155,942 | $3,058 |
| Descovy | 76 | $129,082 | $1,698 |
| Genvoya | 37 | $111,856 | $3,023 |
| Prezcobix | 44 | $79,187 | $1,800 |
| Triumeq | 21 | $58,683 | $2,794 |
| Selzentry | 38 | $57,363 | $1,510 |
| Voriconazole | 25 | $55,374 | $2,215 |
| Odefsey | 18 | $48,045 | $2,669 |
| Intelence | 17 | $20,935 | $1,231 |
| Evotaz | 12 | $19,530 | $1,627 |
| Mycamine | 12 | $17,088 | $1,424 |
| Androgel | 12 | $7,969 | $664 |
| Combivent Respimat | 11 | $4,086 | $371 |
| Cefepime | 11 | $3,613 | $328 |
| Abacavir | 16 | $3,283 | $205 |
| Fluconazole | 17 | $3,215 | $189 |
| Lamivudine | 14 | $2,869 | $205 |
| Vancomycin | 15 | $2,661 | $177 |
| Ventolin Hfa | 42 | $2,267 | $54 |
| Omega-3 Acid Ethyl Esters | 17 | $1,825 | $107 |
| Rifampin | 14 | $1,066 | $76 |
| Cephalexin | 20 | $1,002 | $50 |
| Amoxicillin-Clavulanate Potass | 27 | $870 | $32 |
| Enalapril Maleate | 64 | $853 | $13 |
| Atorvastatin | 71 | $536 | $8 |
| Gabapentin | 26 | $521 | $20 |
| Doxycycline Monohydrate | 15 | $504 | $34 |
| Levetiracetam | 26 | $400 | $15 |
| Celecoxib | 13 | $374 | $29 |
| Levothyroxine | 17 | $326 | $19 |
| Amoxicillin | 12 | $272 | $23 |
| Levofloxacin | 20 | $217 | $11 |
| Omeprazole | 40 | $194 | $5 |
| Valacyclovir | 12 | $181 | $15 |
| Sulfamethoxazole-Trimethoprim | 31 | $133 | $4 |
| Fluticasone Propionate | 19 | $125 | $7 |
| Pravastatin | 12 | $104 | $9 |
| Mirtazapine | 13 | $79 | $6 |
| Citalopram Hbr | 15 | $69 | $5 |
| Benazepril | 13 | $68 | $5 |
| Atenolol | 13 | $65 | $5 |
| Finasteride | 12 | $60 | $5 |
| Amlodipine Besylate | 38 | $57 | $1 |
2017: 42 drugs
| Tivicay | 110 | $188,541 | $1,714 |
| Genvoya | 36 | $102,093 | $2,836 |
| Descovy | 60 | $96,719 | $1,612 |
| Odefsey | 27 | $68,503 | $2,537 |
| Prezcobix | 35 | $59,287 | $1,694 |
| Selzentry | 42 | $59,001 | $1,405 |
| Daptomycin | 11 | $54,633 | $4,967 |
| Triumeq | 17 | $43,279 | $2,546 |
| Truvada | 26 | $41,169 | $1,583 |
| Evotaz | 12 | $19,634 | $1,636 |
| Vancomycin | 53 | $6,800 | $128 |
| Abacavir | 25 | $4,239 | $170 |
| Combivent Respimat | 12 | $4,139 | $345 |
| Lamivudine | 14 | $2,509 | $179 |
| Cefepime | 14 | $2,468 | $176 |
| Lamivudine-Zidovudine | 11 | $2,377 | $216 |
| Omega-3 Acid Ethyl Esters | 15 | $1,886 | $126 |
| Doxycycline Hyclate | 20 | $1,821 | $91 |
| Azithromycin | 15 | $1,496 | $100 |
| Ventolin Hfa | 20 | $1,068 | $53 |
| Sulfamethoxazole-Trimethoprim | 37 | $997 | $27 |
| Amoxicillin-Clavulanate Potass | 23 | $968 | $42 |
| Ceftriaxone | 25 | $926 | $37 |
| Fluconazole | 11 | $673 | $61 |
| Enalapril Maleate | 36 | $453 | $13 |
| Atorvastatin | 54 | $433 | $8 |
| Doxycycline Monohydrate | 16 | $425 | $27 |
| Valacyclovir | 17 | $407 | $24 |
| Levofloxacin | 23 | $259 | $11 |
| Cephalexin | 17 | $258 | $15 |
| Levetiracetam | 16 | $246 | $15 |
| Gabapentin | 18 | $180 | $10 |
| Fluticasone Propionate | 15 | $155 | $10 |
| Levothyroxine | 11 | $128 | $12 |
| Acyclovir | 14 | $120 | $9 |
| Omeprazole | 21 | $83 | $4 |
| Isoniazid | 13 | $80 | $6 |
| Finasteride | 12 | $70 | $6 |
| Sertraline | 12 | $60 | $5 |
| Benazepril | 12 | $54 | $5 |
| Carvedilol | 12 | $37 | $3 |
| Amlodipine Besylate | 13 | $16 | $1 |
2016: 34 drugs
| Genvoya | 36 | $93,832 | $2,606 |
| Tivicay | 65 | $92,018 | $1,416 |
| Truvada | 55 | $80,862 | $1,470 |
| Selzentry | 47 | $60,370 | $1,284 |
| Odefsey | 20 | $47,530 | $2,377 |
| Epzicom | 21 | $26,954 | $1,284 |
| Prezcobix | 12 | $18,977 | $1,581 |
| Isentress | 13 | $17,043 | $1,311 |
| Oxacillin | 13 | $12,248 | $942 |
| Lyrica | 11 | $5,727 | $521 |
| Ceftriaxone | 23 | $5,709 | $248 |
| Doxycycline Hyclate | 35 | $4,169 | $119 |
| Cefepime | 23 | $3,938 | $171 |
| Abacavir | 15 | $3,902 | $260 |
| Zetia | 12 | $3,341 | $278 |
| Ampicillin-Sulbactam | 20 | $3,332 | $167 |
| Vancomycin | 19 | $1,766 | $93 |
| Omega-3 Acid Ethyl Esters | 11 | $1,422 | $129 |
| Amoxicillin-Clavulanate Potass | 26 | $1,044 | $40 |
| Valacyclovir | 21 | $879 | $42 |
| Ventolin Hfa | 14 | $730 | $52 |
| Testosterone Cypionate | 22 | $720 | $33 |
| Fluconazole | 13 | $715 | $55 |
| Azithromycin | 11 | $584 | $53 |
| Hydrocodone-Acetaminophen | 12 | $424 | $35 |
| Levofloxacin | 26 | $420 | $16 |
| Atorvastatin | 39 | $362 | $9 |
| Levothyroxine | 27 | $314 | $12 |
| Gabapentin | 16 | $84 | $5 |
| Famotidine | 14 | $56 | $4 |
| Sulfamethoxazole-Trimethoprim | 20 | $55 | $3 |
| Omeprazole | 17 | $52 | $3 |
| Carvedilol | 12 | $29 | $2 |
| Amlodipine Besylate | 13 | $22 | $2 |
2015: 25 drugs
| Truvada | 112 | $152,533 | $1,362 |
| Isentress | 66 | $80,264 | $1,216 |
| Tivicay | 48 | $63,296 | $1,319 |
| Selzentry | 49 | $58,887 | $1,202 |
| Epzicom | 22 | $26,151 | $1,189 |
| Reyataz | 14 | $18,312 | $1,308 |
| Kaletra | 12 | $10,216 | $851 |
| Doxycycline Hyclate | 70 | $9,685 | $138 |
| Vancomycin | 28 | $4,293 | $153 |
| Norvir | 16 | $4,270 | $267 |
| Abacavir | 11 | $3,112 | $283 |
| Zetia | 12 | $2,752 | $229 |
| Ceftriaxone | 15 | $2,545 | $170 |
| Proair Hfa | 18 | $924 | $51 |
| Duloxetine | 13 | $871 | $67 |
| Doxycycline Monohydrate | 15 | $860 | $57 |
| Valacyclovir | 22 | $685 | $31 |
| Ventolin Hfa | 14 | $675 | $48 |
| Amoxicillin-Clavulanate Potass | 20 | $642 | $32 |
| Levofloxacin | 29 | $461 | $16 |
| Levothyroxine | 36 | $393 | $11 |
| Atorvastatin | 34 | $285 | $8 |
| Sodium Chloride | 15 | $228 | $15 |
| Sulfamethoxazole-Trimethoprim | 22 | $131 | $6 |
| Carvedilol | 12 | $38 | $3 |
2014: 27 drugs
| Truvada | 89 | $117,238 | $1,317 |
| Isentress | 67 | $77,217 | $1,152 |
| Selzentry | 33 | $37,963 | $1,150 |
| Tivicay | 24 | $35,152 | $1,465 |
| Prezista | 13 | $15,408 | $1,185 |
| Lamivudine-Zidovudine | 22 | $14,835 | $674 |
| Epzicom | 13 | $14,500 | $1,115 |
| Kaletra | 17 | $14,250 | $838 |
| Viread | 15 | $13,434 | $896 |
| Intelence | 12 | $11,743 | $979 |
| Doxycycline Hyclate | 62 | $10,510 | $170 |
| Norvir | 20 | $7,124 | $356 |
| Abacavir | 16 | $5,673 | $355 |
| Zetia | 12 | $2,342 | $195 |
| Vancomycin | 16 | $1,499 | $94 |
| Levofloxacin | 33 | $880 | $27 |
| Fluconazole | 11 | $799 | $73 |
| Clotrimazole | 13 | $441 | $34 |
| Levothyroxine | 34 | $308 | $9 |
| Atorvastatin | 30 | $280 | $9 |
| Isoniazid | 27 | $202 | $7 |
| Sulfamethoxazole-Trimethoprim | 16 | $180 | $11 |
| Benazepril | 23 | $176 | $8 |
| Amoxicillin | 11 | $112 | $10 |
| Ibuprofen | 13 | $97 | $7 |
| Carvedilol | 12 | $68 | $6 |
| Ranitidine | 12 | $67 | $6 |
2013: 35 drugs
| Truvada | 78 | $98,294 | $1,260 |
| Isentress | 74 | $81,281 | $1,098 |
| Cubicin | 23 | $35,780 | $1,556 |
| Selzentry | 23 | $25,533 | $1,110 |
| Reyataz | 20 | $21,795 | $1,090 |
| Epzicom | 20 | $20,352 | $1,018 |
| Prezista | 18 | $19,990 | $1,111 |
| Meropenem | 24 | $19,422 | $809 |
| Kaletra | 23 | $18,127 | $788 |
| Norvir | 37 | $12,020 | $325 |
| Intelence | 12 | $11,008 | $917 |
| Doxycycline Hyclate | 59 | $9,809 | $166 |
| Cefepime | 16 | $7,294 | $456 |
| Androgel | 11 | $4,102 | $373 |
| Vancomycin | 40 | $3,289 | $82 |
| Cymbalta | 12 | $2,355 | $196 |
| Zetia | 11 | $1,812 | $165 |
| Sodium Chloride | 17 | $1,306 | $77 |
| Creon | 12 | $1,218 | $101 |
| Levofloxacin | 21 | $880 | $42 |
| Sulfamethoxazole-Trimethoprim | 16 | $756 | $47 |
| Ramipril | 12 | $517 | $43 |
| Azithromycin | 11 | $304 | $28 |
| Fluconazole | 12 | $301 | $25 |
| Levothyroxine | 36 | $205 | $6 |
| Isoniazid | 21 | $198 | $9 |
| Gabapentin | 14 | $162 | $12 |
| Amoxicillin | 12 | $161 | $13 |
| Venlafaxine Hcl Er | 12 | $159 | $13 |
| Benazepril | 18 | $133 | $7 |
| Omeprazole | 16 | $126 | $8 |
| Mirtazapine | 12 | $86 | $7 |
| Carvedilol | 13 | $81 | $6 |
| Ranitidine | 11 | $64 | $6 |
| Hydrochlorothiazide | 11 | $35 | $3 |
Money from drug and device companies
$48 in 2025
| 2025 | 2 | 2 | None | $48 |
| 2024 | 2 | 2 | None | $34 |
| 2019 | 2 | 2 | None | $134 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Wegovy | $26 | 1 payment
|
| Sanofi Pasteur | Beyfortus | $22 | 1 payment
|
See all 2 published payments
| Sanofi Pasteur | Meals · 2025-05-13 | Beyfortus | $22 |
| Novo Nordisk | Meals · 2025-04-08 | Wegovy | $26 |
See earlier years (2024, 2019)
2024: $34
| Hologic Sales and Service | Thinprep 2000 Processor | $19 | 1 payment
|
| Novo Nordisk | None | $14 | 1 payment
|
2019: $134
| Gilead Sciences | None | $117 | 1 payment
|
| Janssen Biotech | Symtuza | $17 | 1 payment
|
Professional record
- NPI
- 1881640399
- Licence
- CA A63095California A63095: Current · expires 2027-02-28
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A630950
- Taxonomy
- Federal specialty code 207RI0200X (207RI0200X)
- Mailing address
- Po Box 31309, Los Angeles, CA, 90031
- NPI first listed
- 2006-05-26
- NPI last updated
- 2014-03-06
This is when the NPI record was last certified, not a medical board exam.